首页 | 本学科首页   官方微博 | 高级检索  
检索        

电离辐射克服NSCLC细胞株H1975吉非替尼耐药的体外研究
引用本文:李静,武新虎,李兵,王振,沈泽天,孙妮,朱锡旭.电离辐射克服NSCLC细胞株H1975吉非替尼耐药的体外研究[J].肿瘤防治研究,2015,42(11):1091-1094.
作者姓名:李静  武新虎  李兵  王振  沈泽天  孙妮  朱锡旭
作者单位:210002南京,南京军区南京总医院,南京大学医学临床学院放射治疗科
基金项目:南京军区南京总医院基金(2014049)
摘    要:目的 探讨电离辐射联合吉非替尼对NSCLC耐药株H1975耐药突变、细胞凋亡及相关蛋白表达的影响及其可能机制。方法 实时荧光定量PCR对不同处理组H1975细胞的T790M突变进行相对定量分析;流式细胞仪检测不同处理组H1975细胞的凋亡率;免疫印迹检测不同处理组凋亡相关蛋白的表达水平。结果 2.5 Gy电离辐射组相较于0 Gy对照组,H1975细胞株T790M突变量降为原来的0.67倍,随电离辐射剂量的增高,T790M突变量降低(P<0.05);电离辐射联合吉非替尼组的细胞凋亡率为(44.35±8.49)%,相较于单独电离辐射组(21.84±5.62)%或吉非替尼组(17.38±6.78)%明显升高(P<0.05);电离辐射联合吉非替尼可诱导H1975细胞中磷酸化表皮生长因子受体(phosphorylated epidermal growth factor receptor, p-EGFR)、磷酸化蛋白激酶B(phosphorylated protein kinase B, p-AKT)蛋白表达水平明显下调。结论 在吉非替尼耐药的NSCLC细胞株H1975中,电离辐射可以克服吉非替尼耐药,与吉非替尼有良好的协同作用。

关 键 词:非小细胞肺癌  药物耐受性  细胞凋亡  T790M突变  信号通路蛋白  
收稿时间:2014-12-10

Ionizing Radiation Overcomes Gefitinib Resistance of Non-small Cell Lung Cancer Cell Line H1975 in vitro
LI Jing,WU Xinhu,LI Bing,WANG Zhen,SHEN Zetian,SUN Ni,ZHU Xixu.Ionizing Radiation Overcomes Gefitinib Resistance of Non-small Cell Lung Cancer Cell Line H1975 in vitro[J].Cancer Research on Prevention and Treatment,2015,42(11):1091-1094.
Authors:LI Jing  WU Xinhu  LI Bing  WANG Zhen  SHEN Zetian  SUN Ni  ZHU Xixu
Institution:Department of Radiation Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China
Abstract:Objective To investigate the effects of ionizing radiation combined with gefitinib on the resistance mutations, apoptosis and expression of apoptosis-related proteins of non-small cell lung cancer(NSCLC) cell line H1975, which had acquired drug resistance, as well as to explore the possible mechanism. Methods The relative quantitation of T790M mutation in H1975 cells treated by different methods was analyzed by real-time PCR. Apoptosis rates in different treatment groups were detected by cytometry (Annexin V-FITC). The expressions of apoptosis-related proteins were detected by Western blot. Results The T790M mutation of H1975 cells in 2.5Gy ionizing radiation group dropped by 0.67 times, compared with 0Gy normal control group; the T790M mutation was reduced as the radiation doses was increased(P<0.05). The rates of cell apoptosis in ionizing radiation combined with gefitinib group (44.35±8.49)% was statistically higher than those in ionizing radiation group(21.84±5.62)%] and gefitinib group(17.38±6.78)%] (P<0.05). The expressions of phosphorylated epidermal growth factor receptor(p-EGFR) and phosphorylated protein kinase B(p-AKT) proteins were significantly decreased by the combination of ionizing radiation and gefitinib. Conclusion For NSCLC cell line H1975 with acquired drug-resistance, ionizing radiation could overcome gefitinib-resistance. The combination of ionizing radiation and gefitinib shows a great synergistic effect.
Keywords:Non-small cell lung cancer(NSCLC)  Drug tolerance  Apoptosis  T790M mutation  Signaling pathway proteins  
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号